{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:06:20Z","timestamp":1788581180768,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejca.2023.03.021","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T12:58:13Z","timestamp":1679662693000},"page":"151-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis"],"prefix":"10.1016","volume":"186","author":[{"given":"Caroline","family":"Bascoul-Mollevi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gourgou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Luc","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rullier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Juzyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Castan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ejca.2023.03.021_bib1","first-page":"1926","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J\u00a0Clin\u00a0Oncol\u00a0Off\u00a0J\u00a0Am\u00a0Soc\u00a0Clin\u00a0Oncol"},{"issue":"36","key":"10.1016\/j.ejca.2023.03.021_bib2","first-page":"4558","article-title":"Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomized trial in rectal cancer","volume":"30","author":"Gerard","year":"2012","journal-title":"J\u00a0Clin\u00a0Oncol\u00a0Off\u00a0J\u00a0Am\u00a0Soc\u00a0Clin\u00a0Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2023.03.021_bib3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.021_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"25","key":"10.1016\/j.ejca.2023.03.021_bib5","first-page":"6199","article-title":"Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients\u00a0\u2013 a Dutch colorectal cancer group study","volume":"23","author":"Peeters","year":"2005","journal-title":"J\u00a0Clin\u00a0Oncol\u00a0Off\u00a0J\u00a0Am\u00a0Soc\u00a0Clin\u00a0Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2023.03.021_bib6","first-page":"1847","article-title":"Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial","volume":"23","author":"Marijnen","year":"2005","journal-title":"J\u00a0Clin\u00a0Oncol\u00a0Off\u00a0J\u00a0Am\u00a0Soc\u00a0Clin\u00a0Oncol"},{"issue":"34","key":"10.1016\/j.ejca.2023.03.021_bib7","first-page":"8697","article-title":"Swedish Rectal Cancer Trial G: adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial","volume":"23","author":"Birgisson","year":"2005","journal-title":"J\u00a0Clin\u00a0Oncol\u00a0Off\u00a0J\u00a0Am\u00a0Soc\u00a0Clin\u00a0Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2023.03.021_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF02235256","article-title":"Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study","volume":"41","author":"Dahlberg","year":"1998","journal-title":"Dis Colon rectum"},{"issue":"6","key":"10.1016\/j.ejca.2023.03.021_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/DCR.0000000000001336","article-title":"Quality of life after curative resection for rectal cancer in patients treated with adjuvant chemotherapy compared with observation: results of the randomized phase III SCRIPT trial","volume":"62","author":"van der Valk","year":"2019","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.ejca.2023.03.021_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"17","key":"10.1016\/j.ejca.2023.03.021_bib11","first-page":"3017","article-title":"Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer","volume":"45","author":"Whistance","year":"2009","journal-title":"Eur\u00a0J\u00a0Cancer (Oxf Engl\u00a01990)"},{"issue":"10","key":"10.1016\/j.ejca.2023.03.021_bib12","first-page":"1564","article-title":"Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire","volume":"43","author":"Gujral","year":"2007","journal-title":"Eur\u00a0J\u00a0Cancer\u00a0(Oxf\u00a0Engl\u00a01990)"},{"issue":"15","key":"10.1016\/j.ejca.2023.03.021_bib13","first-page":"2243","article-title":"French version of FACT-G: validation and comparison with other cancer-specific instruments","volume":"40","author":"Conroy","year":"2004","journal-title":"Eur\u00a0J\u00a0Cancer\u00a0(Oxf\u00a0Engl\u00a01990)"},{"key":"10.1016\/j.ejca.2023.03.021_bib14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1477-7525-9-70","article-title":"Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer","volume":"9","author":"Uwer","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ejca.2023.03.021_bib15","series-title":"EORTC QLQ-C30 scoring manual","author":"Fayers","year":"2001"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.021_bib16","first-page":"91","article-title":"Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results","volume":"30","author":"Bascoul-Mollevi","year":"2021","journal-title":"Qual\u00a0Life Res\u00a0Int\u00a0J\u00a0Qual\u00a0Asp\u00a0Treat\u00a0Care\u00a0Rehabil"},{"issue":"2","key":"10.1016\/j.ejca.2023.03.021_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/cncr.28382","article-title":"A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites","volume":"120","author":"Quinten","year":"2014","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2023.03.021_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","article-title":"Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials","volume":"10","author":"Quinten","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.021_bib19","first-page":"407","article-title":"Measurement of health status","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin\u00a0Trials"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.021_bib20","first-page":"139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J\u00a0Clin\u00a0Oncol\u00a0Off\u00a0J\u00a0Am\u00a0Soc\u00a0Clin\u00a0Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2023.03.021_bib21","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"issue":"9804","key":"10.1016\/j.ejca.2023.03.021_bib22","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(11)61256-7","article-title":"Reporting quality of life in clinical trials: a CONSORT extension","volume":"378","author":"Calvert","year":"2011","journal-title":"Lancet (Lond\u00a0Engl)"},{"key":"10.1016\/j.ejca.2023.03.021_bib23","first-page":"69","article-title":"Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer \u2013 the RAPIDO trial","volume":"171","author":"Dijkstra","year":"2022","journal-title":"Radiother\u00a0Oncol\u00a0J\u00a0Eur\u00a0Soc\u00a0Ther\u00a0Radiol\u00a0Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2023.03.021_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijrobp.2015.03.038","article-title":"Short- and long-term quality of life and bowel function in patients with MRI-defined, high-risk, locally advanced rectal cancer treated with an intensified neoadjuvant strategy in the randomized phase 2 EXPERT-C trial","volume":"93","author":"Sclafani","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ejca.2023.03.021_bib25","first-page":"CD004323","article-title":"Quality of life after rectal resection for cancer, with or without permanent colostomy","author":"Pachler","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ejca.2023.03.021_bib26","first-page":"354","article-title":"Quality of life among disease-free survivors of rectal cancer","volume":"22","author":"Rauch","year":"2004","journal-title":"J\u00a0Clin\u00a0Oncol\u00a0Off\u00a0J\u00a0Am\u00a0Soc\u00a0Clin\u00a0Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2023.03.021_bib27","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1245\/s10434-007-9402-z","article-title":"A meta-analysis of quality of life for abdominoperineal excision of rectum versus anterior resection for rectal cancer","volume":"14","author":"Cornish","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2023.03.021_bib28","article-title":"Quality of life after sphincter preservation surgery or abdominoperineal resection for low rectal cancer (ASPIRE): a long-term prospective, multicentre, cohort study","volume":"6","author":"Kang","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.021_bib29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00595-015-1217-0","article-title":"Effects of robotic rectal surgery on sexual and urinary functions in male patients","volume":"46","author":"Ozeki","year":"2016","journal-title":"Surg Today"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.021_bib30","first-page":"23","article-title":"Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4\/ACCORD 11 randomized trial","volume":"31","author":"Gourgou-Bourgade","year":"2013","journal-title":"J\u00a0Clin\u00a0Oncol Off\u00a0J\u00a0Am Soc\u00a0Clin\u00a0Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2023.03.021_bib31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jval.2020.10.017","article-title":"Patient-reported outcomes as independent prognostic factors for survival in oncology: systematic review and meta-analysis","volume":"24","author":"Efficace","year":"2021","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.ejca.2023.03.021_bib32","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e31824f1c21","article-title":"Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer","volume":"255","author":"Emmertsen","year":"2012","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.021_bib33","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/SLA.0b013e31828fac0b","article-title":"International validation of the low anterior resection syndrome score","volume":"259","author":"Juul","year":"2014","journal-title":"Ann Surg"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923001569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923001569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:40:24Z","timestamp":1760733624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923001569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":33,"alternative-id":["S0959804923001569"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.03.021","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}